(Q24248651)

26 June 2017

1 reference

https://doi.org/10.1002/14651858.CD003352.pub2

1 reference

29 December 2023

http://retractionwatch.com/2010/09/20/progressive-how-the-cochrane-library-handles-updates-in-progress/

title

Dopamine agonists for cocaine dependence (English)

1 reference

26 June 2017

0 references

1 reference

1 reference

Bernardo Soares

1

0 references

Anelise ARL Lima Reisser

2

0 references

Michael Farrell

3

0 references

Maurício Silva de Lima

4

0 references

B G Soares

1

1 reference

26 June 2017

M S Lima

2

1 reference

26 June 2017

A A Reisser

3

1 reference

26 June 2017

M Farrell

4

1 reference

26 June 2017

B G O Soares

1

0 references

A A P Reisser

3

0 references

language of work or name

English

0 references

publication date

22 April 2003

0 references

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

26 June 2017

2003

0 references

published in

1 reference

26 June 2017

CD003352

1 reference

26 June 2017

4

1 reference

Treatment of Cocaine Dependence in Methadone Maintenance Clients: A Pilot Study Comparing the Efficacy of Desipramine and Amantadine

26 June 2017

2

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

A placebo-controlled trial of L-dopa/carbidopa in early cocaine abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

Bromocriptine therapy in cocaine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

Bromocriptine-desipramine protocol in treatment of cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

Incentives improve outcome in outpatient behavioral treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Double-blind evaluation of the effect of acute amantadine on cocaine craving.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Cocaine-induced cocaine craving.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

A randomized trial of bromocriptine for cocaine users presenting to the emergency department.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Effects of bromocriptine pretreatment on subjective and physiological responses to i.v. cocaine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Single-dose bromocriptine reverses cocaine craving

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Bromocriptine and amantadine in cocaine detoxification.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Dopaminergic responsivity during cocaine abstinence: a pilot study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Amantadine may facilitate detoxification of cocaine addicts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Bromocriptine as treatment of cocaine abuse.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Methadone tapering plus amantadine to detoxify heroin-dependent inpatients with or without an active cocaine use disorder: two randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

A screening trial of amantadine as a medication for cocaine dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Cocaine dependence: a disease of the brain's reward centers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Open-label pilot study of bupropion plus bromocriptine for treatment of cocaine dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Diethylpropion pharmacotherapeutic adjuvant therapy for inpatient treatment of cocaine dependence: a test of the cocaine-agonist hypothesis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Bromocriptine and cocaine cue reactivity in cocaine-dependent patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Adverse outcomes in a controlled trial of pergolide for cocaine dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Double-blind comparison of bromocriptine and placebo in cocaine withdrawal.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352

7 January 2021

Pergolide mesylate for cocaine abuse: a controlled preliminary trial.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003352

Identifiers

DOI

10.1002/14651858.CD003352

1 reference

26 June 2017

1 reference